Skip to content

Postoperative Rotational Dynamics of Three Toric Intraocular Lens Designs

Postoperative Rotational Dynamics of Different Toric Intraocular Lens Designs

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07453992
Acronym
3 TORIC ROTATE
Enrollment
400
Registered
2026-03-06
Start date
2025-01-01
Completion date
2030-12-31
Last updated
2026-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

toric intraocular lens, rotational stability, cataract, astigmatism

Brief summary

This prospective comparative cohort study evaluates and compares postoperative rotational stability and time-course dynamics of three commercially available toric intraocular lenses (TECNIS Toric II \[ZCU\], AcrySof IQ Toric, and AT TORBI 709M) after phacoemulsification cataract surgery. Rotation is quantified by registering postoperative retroillumination photographs to the end-of-surgery baseline using iris/scleral landmarks, with follow-up at postoperative day 1, day 3, week 1, week 2, month 1, and month 3. Associations between rotational outcomes and ocular biometric parameters are analyzed using linear mixed-effects models to inform individualized IOL selection and perioperative management.

Interventions

DEVICETECNIS Toric II (ZCU)

Using TECNIS Toric II (ZCU) intraocular lens during standard phacoemulsification cataract surgery.

DEVICEAcrySof IQ Toric

Using AcrySof IQ Toric intraocular lens during standard phacoemulsification cataract surgery.

Using the AT TORBI 709M intraocular lens during standard phacoemulsification cataract surgery.

Sponsors

Jin Yang
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Outcome assessors were masked to IOL type.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 years or older with age-related cataract scheduled for phacoemulsification cataract surgery. * Presence of regular corneal astigmatism requiring toric intraocular lens implantation. * Eligible for implantation of one of the three study toric intraocular lenses based on preoperative evaluation. * Ability to understand the study procedures and provide written informed consent.

Exclusion criteria

* History of prior ocular surgery in the study eye. * History of ocular trauma in the study eye. * Irregular corneal astigmatism or corneal pathology affecting reliable biometric measurement. * Intraoperative complications, including anterior capsular tear or posterior capsular rupture. * Inadequate pupillary dilation during surgery or postoperative examinations. * Evidence of zonular weakness, zonular dialysis, or lens subluxation. * Active ocular infection or inflammation. * Any other ocular or systemic condition judged by the investigator to potentially affect intraocular lens stability or study outcomes.

Design outcomes

Primary

MeasureTime frameDescription
Absolute rotational misalignment of toric intraocular lens (IOL) measured in degreesPostoperative day 1, day 3, week 1, week 2, month 1, and month 3.Absolute rotation of the implanted toric intraocular lens (IOL) relative to the intended axis, measured in degrees. Rotation will be quantified by registering postoperative retroillumination images to the end-of-surgery baseline frame using iris or scleral landmarks. The absolute rotation angle will be calculated for each follow-up visit.

Secondary

MeasureTime frameDescription
Uncorrected and corrected distance visual acuity (UDVA and CDVA)postoperatively on 1 day, 3 days, 1 week, 2 weeks, 1 month and 3 monthsUncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) measured using a standardized logarithm of the minimum angle of resolution (logMAR) visual acuity chart during follow-up.
Postoperative residual refractive astigmatism measured in dioptersPostoperative day 1, day 3, week 1, week 2, month 1, and month 3.Residual refractive astigmatism measured by manifest refraction during follow-up visits and reported in diopters (D).

Countries

China

Contacts

CONTACTXuanqiao Lin
1532483480@qq.com+8615088920668
PRINCIPAL_INVESTIGATORJin Yang

Fudan University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026